Literature DB >> 36203784

Optimisation of imaging parameters during CT guided interventional procedures in patients with total hip arthroplasty.

Anish Patel1, Christine Azzopardi1, Scott Evans2, A Mark Davies1, Steven James1, Rajesh Botchu1.   

Abstract

Objective: To determine the optimal KV and mAs settings during CT guided injections in the presence of a total hip arthroplasty so that image quality is maintained whist keeping the dose as low as reasonably achievable.
Methods: A total hip arthroplasty phantom with needles with differing gauges was scanned using different CT parameters (from low dose to high dose) and evaluating if this had any effect on needle conspicuity. Conspicuity was graded from 1 to 3 by 2 independent blinded reviewers.
Results: Irrespective of the CT settings used (high dose or low dose parameters) needle conspicuity was not adversely affected by the THA for either scorer, therefore a kVp of 100 mA and a. In addition the needle gauge did not affect the conspicuity of the needle.
Conclusion: CT guided injections in this total hip arthroplasty phantom model can be performed without any adverse effect on the conspicuity of the needle tip on low dose CT settings. Advancement in knowledge: This paper enables one to optimise the kV and mA while performing interventional procedures.
© 2022 Delhi Orthopedic Association. All rights reserved.

Entities:  

Keywords:  CT; Intervention; Total hip arthroplasty

Year:  2022        PMID: 36203784      PMCID: PMC9531172          DOI: 10.1016/j.jcot.2022.102028

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  13 in total

1.  CT-guided biopsy of small liver lesions: visibility, artifacts, and corresponding diagnostic accuracy.

Authors:  Joerg Stattaus; Hilmar Kuehl; Susanne Ladd; Tobias Schroeder; Gerald Antoch; Hideo A Baba; Joerg Barkhausen; Michael Forsting
Journal:  Cardiovasc Intervent Radiol       Date:  2007 Sep-Oct       Impact factor: 2.740

2.  Total hip replacement in patients younger than thirty years old. A five-year follow-up study.

Authors:  H P Chandler; F T Reineck; R L Wixson; J C McCarthy
Journal:  J Bone Joint Surg Am       Date:  1981-12       Impact factor: 5.284

3.  "Modes of failure" of cemented stem-type femoral components: a radiographic analysis of loosening.

Authors:  T A Gruen; G M McNeice; H C Amstutz
Journal:  Clin Orthop Relat Res       Date:  1979-06       Impact factor: 4.176

4.  Cementless total hip arthroplasty in patients with steroid-induced avascular necrosis of the hip. A 62-month follow-up study.

Authors:  F M Phillips; L A Pottenger; H A Finn; J Vandermolen
Journal:  Clin Orthop Relat Res       Date:  1994-06       Impact factor: 4.176

5.  Polyethylene debris-induced osteolysis and loosening in uncemented total hip arthroplasty. A cause of late failure.

Authors:  R A Cooper; C M McAllister; L S Borden; T W Bauer
Journal:  J Arthroplasty       Date:  1992-09       Impact factor: 4.757

Review 6.  Mechanism and clinical significance of wear debris-induced osteolysis.

Authors:  H C Amstutz; P Campbell; N Kossovsky; I C Clarke
Journal:  Clin Orthop Relat Res       Date:  1992-03       Impact factor: 4.176

7.  The prevalence of femoral osteolysis associated with components inserted with or without cement in total hip replacements. A retrospective matched-pair series.

Authors:  D D Goetz; E J Smith; W H Harris
Journal:  J Bone Joint Surg Am       Date:  1994-08       Impact factor: 5.284

8.  Long-term follow-up of total hip replacement in patients with avascular necrosis.

Authors:  E A Salvati; C N Cornell
Journal:  Instr Course Lect       Date:  1988

Review 9.  The painful total hip replacement: diagnosis and deliverance.

Authors:  B A Lanting; S J MacDonald
Journal:  Bone Joint J       Date:  2013-11       Impact factor: 5.082

10.  Future projections of total hip and knee arthroplasty in the UK: results from the UK Clinical Practice Research Datalink.

Authors:  D Culliford; J Maskell; A Judge; C Cooper; D Prieto-Alhambra; N K Arden
Journal:  Osteoarthritis Cartilage       Date:  2015-01-09       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.